The FTC has recently provided new guidance on the use of AI and algorithms, including a blog post that focuses on the benefits and risks of AI in the “Health AI” space. Former FTC Commissioner Terrell McSweeny, AI Initiative Co-Chair Lee Tiedrich, and Jadzia Pierce discuss the post, along with other AI-focused guidance from the … Continue Reading
On April 8, 2020, the Federal Trade Commission (“FTC”) released a blog post about the use of artificial intelligence (“AI”) and algorithms in automated decisionmaking. The blog highlighted the potentially great benefits and risks presented by increasingly sophisticated technologies, particularly in the “Health AI” space. However, it also emphasized that automated decisionmaking is not a new phenomenon—and … Continue Reading